Fennec Pharmaceuticals Inc. · NASDAQ:FENC
Andrade Robert received 1,703 Fennec Pharmaceuticals Inc. shares as an award (Form 4)
Traded Oct 31, 2026 · Filed Nov 2, 2026
On Oct 31, 2026, Andrade Robert (CHIEF FINANCIAL OFFICER) received 1,703 Fennec Pharmaceuticals Inc. shares as an award, leaving 248,558 shares. Filed Nov 2, 2026 (Form 4).
- Awarded
- 1,703 shares
- Holding after
- 248,558 shares
- Trading plan
- No
- Role
- CHIEF FINANCIAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 31, 2026 | Common shares | Award | 1,703 | 248,558 | Direct |
Source
Download original · View original at SEC
Related
- Fennec Pharmaceuticals Inc.
- Andrade Robert
- Fennec Pharmaceuticals Inc. shareholders
- Form 4 · Andrade Robert · Oct 13, 2026
- Form 4 · Andrade Robert · Oct 1, 2026
- Form 4 · Andrade Robert · Aug 31, 2026
- Form 4 · Andrade Robert · Aug 28, 2026
- Form 4 · Andrade Robert · Aug 3, 2026
- Form 4 · Brughera Marco Maria · Nov 16, 2026
- Schedule 13G/A · Lawrence Kam · Nov 16, 2026
- Schedule 13G/A · Solas Capital Management, LLC · Nov 16, 2026
- Form 4 · Cioffi Christiana Marie · Nov 2, 2026
- Form 4 · Evans Terry L · Nov 2, 2026